Abstract| Volume 135, ISSUE 2, P384, November 2014

Occult and subsequent gynecologic cancers following risk-reducing salpingo-oophorectomies (RRSO) in BRCA mutation carriers

      Objectives: Occult and subsequent pelvic serous carcinomas have been reported following RRSO in BRCA1 and 2 mutation carriers. The frequency and clinico-pathologic features of these tumors and recommendations regarding follow up are provided.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect